INDUCTION OF HEMOGLOBIN-SYNTHESIS IN HUMAN-LEUKEMIC K 562-CELLS BY ADRIAMYCIN
- 1 January 1984
- journal article
- research article
- Vol. 4 (1-2) , 47-51
Abstract
The antitumor compound adriamycin was found to induce differentiation-associated properties in human erythroleukemia K-562 cells. Studies on the relationship between drug concentration and the appearance of Hb demonstrated that, the more the rate of cell division was reduced during the 4 days of exposure, the higher was the accumulation of Hb per cell. Considering the variation in the intracellular protein content during the response, it appears that adriamycin (40 nM) stimulated the synthesis of both Hb and non-Hb proteins while hemin, a well-known erythroid inducer, specifically increased Hb synthesis. In addition, the lack of cell growth was associated with a recruitment of benzidine-positive cells. In contrast to hemin, adriamycin did not modify the electrophoretic pattern found in untreated cells.This publication has 11 references indexed in Scilit:
- The Anticancer Agent Adriamycin Can Be Actively Cytotoxic Without Entering CellsScience, 1982
- Synthesis of adriamycin-coupled polyglutaraldehyde microspheres and evaluation of their cytostatic activity.Proceedings of the National Academy of Sciences, 1982
- STRUCTURE-ACTIVITY-RELATIONSHIPS FOR THE INDUCTION OF DIFFERENTIATION OF HL-60 HUMAN ACUTE PROMYELOCYTIC LEUKEMIA-CELLS BY ANTHRACYCLINES1982
- A spectrophotometric method for measuring hemoglobin in erythroleukemic cells (K562).Journal of Histochemistry & Cytochemistry, 1981
- Induction of Hemoglobin Accumulation in Human K562 Cells by Hemin Is ReversibleScience, 1981
- DIFFERENTIAL EXPRESSION OF THE GLOBIN GENES IN HUMAN LEUKEMIA-K562(S) CELLS INDUCED TO DIFFERENTIATE BY HEMIN OR BUTYRIC-ACID1981
- INHIBITORS OF CELL-DIVISION REVERSIBLY MODIFY HEMOGLOBIN CONCENTRATION IN HUMAN ERYTHROLEUKEMIA K562 CELLS1981
- Embryonic erythroid differentiation in the human leukemic cell line K562.Proceedings of the National Academy of Sciences, 1981
- Potential pre‐screening for therapeutic agents that induce differentiation in human myeloid leukemia cellsInternational Journal of Cancer, 1980
- Deficient heme synthesis as the cause of noninducibility of hemoglobin synthesis in a friend erythroleukemia cell lineCell, 1979